1
ResearchHighlightsVol.26 , No.3 , 2018 SCIENCEFOUNDATIONINCHINA AlossGofGfunctionmutationin LIMA1 decreasesintestinalcholesterolabsor p tion and p reventscardiovasculardisease SupportedbytheNationalNaturalScienceFoundationofChina , acollaborativestudybythelaboratories ofDr.SongBaoLiang ( 宋保亮 ) from WuhanUniversityandDr.MaYiTong ( 马依彤 ) from theFirst AffiliatedHospitalofXinjiang MedicalUniversitydemonstratesthatarareframeshift mutationinthe LIMA1 genepromoteslow plasmalowGdensitylipoproteincholesterol ( LDLGC ) anddecreasesintestinal Figure LIMA1regulatesintestinalcholesterolabsorption byanchoringNPC1L1tomyosinVb.A ; Pedigreeofthe Kazakhfamily withlowerlevelsofplasmaLDLGC ; B , identification ofthe LIMA1 mutationinlow LDLGC members ; C , SchematicmodelofNPC1L1GLIMA1Gmyosin Vbinteraction. cholesterolabsorption.Thisworkwasrecentlypublishedin Science ( 2018 , 360 ( 6393 ): 1087 1092 ) Cholesterolisanessentialcomponentofeukaryotic membranesandtheprecursorto manybiological activemolecules.Itcan besynthesizeddenovo andobtainedfrom thediet.However , toomuchlowG densitylipoproteinGcholesterol ( LDLGC ) intheplasmaisamajorriskfactorforcoronaryheartdiseaseand stroke.ThegeneticfactorsaffectingLDLGChavenotbeenfullycharacterized. Tosearchfor LDLGCGassociated mutations , theteamsled by Dr.Songand Dr.Maconducteda cardiovascularrisksurveyin Xinjiang UygurAutonomousRegionofChinaandfoundaChinese Kazakh familywithinheritedlowlevelsofLDLGCandreducedcholesterolabsorption.WholeGexomesequencing andgenomeGwidelinkageanalysisrevealedthattheLIMA1 GK306fsvariant wasassociated withlower plasmaLDLGCofthisfamily.The LIMA1 gene ( alsoknownas EPLIN or SREBP3 ) hasnotbeenlinked tolipidmetabolism priortothestudy , andtheLIMA1 GK306fs mutation hasnotbeenreportedinany publisheddatabases.Inmice , LIMA1 washighlyexpressedbythebrushbordermembraneofthesmall intestine.Ablationof LIMA1inthesmallintestineimpaireddietarycholesterolabsorptionandameliorated dietGinduced hypercholesterolemia.Atthe mechanisticlevel , LIMA1interacted with NiemannGPickC1Glike1 ( NPC1L1 ) and myosin Vb.NPC1L1isakeyproteinthat shuttlesbetweentheplasmamembrane ( PM ) andtheendocyticrecyclingcompartmentto mediateintestinalcholesterolabsorption , and themolecularpathwayofNPC1L1Gdependent cholesteroluptake hasbeensystematically characterizedbyDr.Songandcolleaguesin the past few years.Theformationof NPC1L1GLIMA1GMyosinVbternarycomplex regulated NPC1L1transportationtothePM and consequently cholesterol absorption throughthesmallintestine.Thesefindings revealthecholesterolregulatory mechanism inhumansandsuggestthatpharmacological targetingthroughthe LIMA1pathway may serveasanewstrategytotreathypercholesG terolemia.

LIMA1 decreasesintestinalcholesterolabsorption andpreventscardiovasculardisease · 2019. 7. 4. · •ResearchHighlights• 4 Vol.26,No.3,2018 SCIENCEFOUNDATIONINCHINA AlossGofGfunctionmutationinLIMA1

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: LIMA1 decreasesintestinalcholesterolabsorption andpreventscardiovasculardisease · 2019. 7. 4. · •ResearchHighlights• 4 Vol.26,No.3,2018 SCIENCEFOUNDATIONINCHINA AlossGofGfunctionmutationinLIMA1

•ResearchHighlights•

4     Vol.26,No.3,2018  SCIENCEFOUNDATIONINCHINA

AlossGofGfunctionmutationinLIMA1decreasesintestinalcholesterolabsorption

andpreventscardiovasculardisease

SupportedbytheNationalNaturalScienceFoundationofChina,acollaborativestudybythelaboratoriesofDr.SongBaoLiang(宋保亮)from WuhanUniversityandDr.MaYiTong (马依彤)fromtheFirstAffiliatedHospitalofXinjiang MedicalUniversitydemonstratesthatarareframeshiftmutationintheLIMA1genepromoteslowplasmalowGdensitylipoproteincholesterol(LDLGC)anddecreasesintestinal

Figure LIMA1regulatesintestinalcholesterolabsorptionbyanchoringNPC1L1tomyosinVb.A;PedigreeoftheKazakhfamily withlowerlevelsofplasma LDLGC;B,identification of the LIMA1 mutation in low LDLGCmembers;C,SchematicmodelofNPC1L1GLIMA1GmyosinVbinteraction.

cholesterolabsorption.ThisworkwasrecentlypublishedinScience(2018,360(6393):1087—1092).Cholesterolisanessentialcomponentofeukaryoticmembranesandtheprecursortomanybiological

activemolecules.Itcanbesynthesizeddenovoandobtainedfromthediet.However,toomuchlowGdensitylipoproteinGcholesterol(LDLGC)intheplasmaisamajorriskfactorforcoronaryheartdiseaseandstroke.ThegeneticfactorsaffectingLDLGChavenotbeenfullycharacterized.

TosearchforLDLGCGassociated mutations,theteamsledby Dr.Songand Dr.MaconductedacardiovascularrisksurveyinXinjiangUygurAutonomousRegionofChinaandfoundaChineseKazakhfamilywithinheritedlowlevelsofLDLGCandreducedcholesterolabsorption.WholeGexomesequencingandgenomeGwidelinkageanalysisrevealedthattheLIMA1GK306fsvariantwasassociated withlowerplasmaLDLGCofthisfamily.TheLIMA1gene(alsoknownasEPLINorSREBP3)hasnotbeenlinkedtolipidmetabolismpriortothestudy,andtheLIMA1GK306fsmutationhasnotbeenreportedinanypublisheddatabases.Inmice,LIMA1washighlyexpressedbythebrushbordermembraneofthesmallintestine.AblationofLIMA1inthesmallintestineimpaireddietarycholesterolabsorptionandameliorateddietGinduced hypercholesterolemia. At themechanisticlevel,LIMA1interacted withNiemannGPick C1Glike 1 (NPC1L1)andmyosinVb.NPC1L1isakeyproteinthatshuttlesbetweentheplasmamembrane(PM)andtheendocyticrecyclingcompartmenttomediateintestinalcholesterolabsorption,andthemolecularpathwayofNPC1L1Gdependentcholesteroluptake has been systematicallycharacterizedbyDr.Songandcolleaguesinthe past few years. The formation ofNPC1L1GLIMA1GMyosinVbternarycomplexregulatedNPC1L1transportationtothePMand consequently cholesterol absorptionthroughthesmallintestine.Thesefindingsrevealthecholesterolregulatory mechanisminhumansandsuggestthatpharmacologicaltargetingthroughtheLIMA1pathway mayserveasanewstrategytotreathypercholesGterolemia.